Targeting Polycystic Ovary Syndrome (PCOS) Pathophysiology with Flavonoids: From Adipokine–Cytokine Crosstalk to Insulin Resistance and Reproductive Dysfunctions
Pharmaceuticals · 18.10.2025 · 18 (10) · 1575
DOI: 10.3390/ph18101575 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Pharmaceuticals, online erschienen am 18.10.2025. Verfasst von Sulagna Dutta und 6 weiteren Autor:innen. Beteiligte Einrichtung: Basic Medical Sciences Department, College of Medicine, Ajman University, Ajman 3464, United Arab Emirates. Die Arbeit wurde bisher 23-mal zitiert (Crossref) und nennt 139 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Polycystic ovary syndrome (PCOS) represents one of the most prevalent endocrine–metabolic disorder in women of reproductive age, which includes but not restricted to reproductive disruptions, insulin resistance (IR), hyperandrogenism, and chronic low-grade inflammation. Its heterogeneous pathophysiology arises from the interplay of metabolic, endocrine, and immune factors, including dysregulated adipokine secretion, cytokine-mediated inflammation, oxidative stress (OS), and mitochondrial dysfunction. Current pharmacological therapies, such as metformin, clomiphene, and oral contraceptives, often provide partial benefits and are limited by side effects, necessitating the exploration of safer, multi-target strategies. Flavonoids, a structurally diverse class of plant-derived polyphenols, have gained attention as promising therapeutic candidates in PCOS due to their antioxidant, anti-inflammatory, insulin-sensitizing, and hormone-modulating properties. Preclinical studies in rodent PCOS models consistently demonstrate improvements in insulin sensitivity, normalization of ovarian morphology, restoration of ovulation, and reduction in hyperandrogenism. Human clinical studies, though limited in scale and heterogeneity, report favorable effects of flavonoids such as quercetin, isoflavones, and catechins on glucose metabolism, adipokine balance, inflammatory markers, and reproductive functions. This evidence-based study critically synthesizes mechanistic insights into how flavonoids modulate insulin signaling, adipokine–cytokine crosstalk, OS, and androgen excess, while highlighting translational evidence and emerging delivery systems aimed at overcoming bioavailability barriers. Collectively, flavonoids represent a promising class of nutraceuticals and adjuncts to conventional therapies, offering an integrative strategy for the management of PCOS.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Basic Medical Sciences Department, College of Medicine, Ajman University, Ajman 3464, United Arab Emirates.
- Department of Biomedical Sciences, College of Medicine, Gulf Medical University, Ajman 4184, United Arab Emirates.
- School of Life Sciences, Manipal Academy of Higher Education (MAHE), Dubai 345050, United Arab Emirates.
- Department of Medical Physiology, Faculty of Medicine, Menoufia University, Shebeen Elkom 6131567, Menofia Governorate, Egypt.
- Department of Microbiology, Faculty of Medicine, Manipal University College Malaysia, Melaka 75150, Malaysia.
- Citmer Reproductive Medicine, Mexico City 11520, Mexico.
ORCID-Profile: Sulagna Dutta, Pallav Sengupta, Ghada Elsayed Elgarawany, Antony Vincent Samrot, Israel Maldonado Rosas, Shubhadeep Roychoudhury
Zitieren
APA
Dutta, S., Sengupta, P., Rao, S., Elgarawany, G. E., Samrot, A. V., Rosas, I. M., & Roychoudhury, S. (2025). Targeting Polycystic Ovary Syndrome (PCOS) Pathophysiology with Flavonoids: From Adipokine–Cytokine Crosstalk to Insulin Resistance and Reproductive Dysfunctions. Pharmaceuticals, 18(10), 1575. https://doi.org/10.3390/ph18101575
Vancouver
Dutta S, Sengupta P, Rao S, Elgarawany GE, Samrot AV, Rosas IM, et al. Targeting Polycystic Ovary Syndrome (PCOS) Pathophysiology with Flavonoids: From Adipokine–Cytokine Crosstalk to Insulin Resistance and Reproductive Dysfunctions. Pharmaceuticals. 2025;18(10):1575. doi:10.3390/ph18101575
BibTeX
@article{Dutta2025,
author = {Dutta, Sulagna and Sengupta, Pallav and Rao, Sowmya and Elgarawany, Ghada Elsayed and Samrot, Antony Vincent and Rosas, Israel Maldonado and Roychoudhury, Shubhadeep},
title = {Targeting Polycystic Ovary Syndrome (PCOS) Pathophysiology with Flavonoids: From Adipokine–Cytokine Crosstalk to Insulin Resistance and Reproductive Dysfunctions},
journal = {Pharmaceuticals},
year = {2025},
volume = {18},
number = {10},
pages = {1575},
doi = {10.3390/ph18101575}
}
EUVIMED